Sample of Oxford/AstraZeneca Covid-19 vaccine

The Food and Drugs Authority (FDA) has denied claims of the AstraZeneca vaccines causing blood clots in the human body.

Its latest update follows reports that the Oxford/AstraZeneca vaccine causes the said condition, forcing France, Germany and other six countries to halt its use.

In a press statement signed by Chief Executive Officer, Delese Darko, the Authority indicated that it constituted a Committee of Experts – the Joint Covid-19 Safety Review Committee (JCVSRC) on February 26, to assess all reported adverse events regarding the use of the vaccines.

According to the FDA, the Committee’s report “concluded that there is currently no causal link between the event [blood clots] and the vaccine, a position that was subsequently upheld by the European Medicines Agency and the World Health Organisation.”

The Authority further added that no events of blood clots linked to the Covishield vaccine have been reported among those who have been vaccinated.

The Food and Drugs Authority is, however, assuring the Ghanaian citizenry that it is closely monitoring the situation locally.

“The Authority continues to work with its Committee of Experts, other regulators globally and will use its established safety monitoring system to support the vaccine to ensure public health and safety,” it stated.

Meanwhile, the FDA acknoweldged that generally, vaccines and medicines tend to have some side effects and this needs to be continually balanced against the expected benefits in preventing illnesses.

These side effects include headaches, fever, chills, body pains, pain at the injection site, weakness, nausea and dizziness.

“These adverse effects are expected from the vaccination and in most cases, resolved within a day or two,” the Authority added.